Stay updated with breaking news from Evolus Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
07.06.2024 - Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a focus on building an aesthetic portfolio of consumer brands, today reported the grant of non-qualified stock options to purchase an aggregate of 30,778 shares of Evolus and an ...
Evolus, Inc. , a performance beauty company with a focus on building an aesthetic portfolio of consumer brands, today reported the grant of non-qualified stock options to purchase an aggregate of...
Evolus (NASDAQ:EOLS – Get Free Report) and Clever Leaves (NASDAQ:CLVR – Get Free Report) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their earnings, valuation, institutional ownership, risk, profitability, analyst recommendations and dividends. Risk and Volatility Evolus has a beta of […]
HC Wainwright reissued their buy rating on shares of Evolus (NASDAQ:EOLS – Free Report) in a report issued on Tuesday morning, Benzinga reports. They currently have a $27.00 price objective on the stock. EOLS has been the subject of a number of other research reports. Barclays upgraded Evolus from an equal weight rating to an […]
On May 13, 2024, Vikram Malik, Director of Evolus Inc (NASDAQ:EOLS), executed a sale of 28,000 shares of the company.